Cue Biopharma, Inc. · NASDAQ:CUE
Lin Shao-Lee sold 11,087 Cue Biopharma, Inc. shares (Form 4)
Traded Oct 12, 2026 · Filed Oct 14, 2026
On Oct 12, 2026, Lin Shao-Lee (Director, Chief Executive Officer) sold 11,087 Cue Biopharma, Inc. shares at an average US$27.55 for US$305K, leaving 694,908 shares. Filed Oct 14, 2026 (Form 4).
- Sold
- 11,087 shares
- Price
- US$27.55 average (US$27.50 to US$28.05)
- Value
- US$305K
- Holding after
- 694,908 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Common Stock | Sale | 10,000 | US$27.50 | 695,995 | Direct |
| Oct 12, 2026 | Common Stock | Sale | 1,087 | US$28.05 | 694,908 | Direct |
Source
Download original · View original at SEC
Related
- Cue Biopharma, Inc.
- Lin Shao-Lee
- Cue Biopharma, Inc. shareholders
- Form 4 · Lin Shao-Lee · Aug 14, 2026
- Form 4 · Lin Shao-Lee · Jul 10, 2026
- Form 4 · Lin Shao-Lee · May 7, 2026
- Form 4 · Ray Sumita · Oct 14, 2026
- Form 4 · Meluzio Michael Vincent · Oct 14, 2026
- Schedule 13G/A · Mark E. Strome · Oct 8, 2026
- Form 4/A · Sarraf Pasha · Aug 28, 2026
- Form 4/A · Garzone Pamela · Aug 28, 2026